Mediwatch PLC Result of AGM and AGM Statement (9054C)
22 Abril 2013 - 6:23AM
UK Regulatory
TIDMMDW
RNS Number : 9054C
Mediwatch PLC
22 April 2013
Mediwatch plc
("Mediwatch" or "the Company" or "the Group")
22 April 2013
Result of AGM and AGM Statement
At 11a.m. today, Omer Karim, Chairman of Mediwatch delivered the
following statement at the Company's annual general meeting:
"It should be no surprise that 2012 was a challenging year.
Whilst in the long term, demographically, urology is a sector with
increasing needs, in the short term health budgets around the world
continue to be under pressure in these straightened times.
Mediwatch has worked hard to maintain profitability by cost cutting
expenses and re-engineering products.
After a long development period, Mediwatch is proud to announce
that it has started selling PSAwatch, a quantitative point-of-care
test for PSA using whole blood. PSAwatch is steadily increasing its
share of the almost 50 million PSA tests that are performed
annually worldwide.
Mediwatch's vision for the future is to develop affordable
equipment for the treatment of conditions in its targeted clinical
areas. 2013 will be a year filled with new product launches. The
first of these a new urodynamic range of Clinic and Encompass, the
new Nano, a new procedure couch and the tablet Portaflow were well
received at European Association of Urologists meeting in Milan in
March. There is more to come later in the year.
I am also pleased to report that the Group is currently trading
in line with management's budgets and, whilst our markets around
the world remain fragile, we expect to meet market expectations for
the year."
All resolutions proposed at the annual general meeting were duly
passed save for resolution 7 (resolution 7 related to
disapplication of pre-emption rights).
Enquiries:
Mediwatch plc
+44 (0)1788 547 888
Dr Philip Stimpson, Chief Executive Officer
Mark Hughes, Chief Financial Officer
SP Angel Corporate Finance LLP
Nomad and broker
+44 (0)20 3463 2260
Ewan Leggat / Laura Littley
This information is provided by RNS
The company news service from the London Stock Exchange
END
AGMLLFFLSFIFFIV
Mediwatch (LSE:MDW)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Mediwatch (LSE:MDW)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024